基于血清微小核糖核酸与临床因素的食管癌内镜黏膜下剥离术后复发预测模型OA
Prediction model for recurrence after endoscopic submucosal dissection of esophageal cancer based on serum microRNAs and clinical factors
目的 探讨整合临床因素及血清微小核糖核酸-204(miR-204)、微小核糖核酸-134(miR-134)构建的预测早期食管癌患者内镜黏膜下剥离术(ESD)后复发风险的机器学习模型的预测价值.方法 按照1∶1比例选取早期食管癌患者作为研究对象,包括ESD后1年内复发患者与未复发患者各100例,分别纳入复发组与未复发组.比较2组患者的临床资料,采用最小绝对收缩与选择算子(LASSO)回归模型筛选变量,构建随机森林(RF)、逻辑回归(LR)、极限梯度提升(XGBoost)、支持向量机(SVM)共4种机器学习模型.绘制受试者工作特征(ROC)曲线,分析4种机器学习模型对早期食管癌ESD后复发的预测效能.另选取早期食管癌ESD后复发患者与未复发患者各50例作为外部验证集,通过校准曲线和决策曲线分析(DCA)对综合预测效能最佳的模型进行验证.结果 2组患者在病变长径、病灶浸润深度、病灶环周范围、切缘阳性及血清miR-204、miR-134水平方面比较,差异有统计学意义(P<0.05).4种机器学习模型中,RF模型预测术后复发的F1分数和曲线下面积(AUC)最高,综合预测效能最佳;RF模型中,重要特征变量排序依次为病灶环周范围、miR-204、miR-134、切缘阳性、病灶浸润深度、病变长径.在外部验证集中,RF模型的C指数为0.892,Brier评分=0.112分;校准曲线、DCA曲线显示,RF模型预测值与实际发生率接近,且其风险阈值范围为15%~100%时,具有显著的净获益.结论 基于病灶环周范围、miR-204、miR-134、切缘阳性、病灶浸润深度、病变长径这6个重要特征变量构建的4种机器学习模型中,RF模型对早期食管癌ESD后复发风险的综合预测效能最佳,具有较高的区分度、准确度及良好的临床适用性.
Objective To explore the predictive value of machine learning models for predicting the recurrence risk after endoscopic submucosal dissection(ESD)in patients with early-stage esopha-geal cancer,which were constructed by integrating clinical factors and serum microRNA-204(miR-204)and microRNA-134(miR-134).Methods Early-stage esophageal cancer patients were selected as the study subjects in a 1∶1 ratio,including 100 patients with recurrence within 1 year af-ter ESD and 100 patients without recurrence,who were respectively included in recurrence group and non-recurrence group.The clinical data of the two groups were compared.The least absolute shrink-age and selection operator(LASSO)regression model was used to screen variables,and four machine learning models,namely random forest(RF),logistic regression(LR),extreme gradient boosting(XGBoost),and support vector machine(SVM),were constructed.The receiver operating characteris-tic(ROC)curve was plotted to analyze the predictive efficacy of the four machine learning models for recurrence after ESD in early-stage esophageal cancer.Additionally,50 patients with recurrence and 50 patients without recurrence after ESD for early-stage esophageal cancer were selected as external validation set to validate the model with the best comprehensive predictive performance through cali-bration curve and decision curve analysis(DCA).Results There were statistically significant differences between the two groups in terms of lesion length,depth of lesion invasion,circumferen-tial extent of the lesion,positive resection margin,and serum levels of miR-204 and miR-134(P<0.05).Among the four machine learning models,the RF model had the highest F1 score and area under the curve(AUC)for predicting postoperative recurrence,demonstrating the best comprehen-sive predictive performance.In the RF model,the important feature variables were ranked in the fol-lowing order:circumferential extent of the lesion,miR-204,miR-134,positive resection margin,depth of lesion invasion,and lesion length.In the external validation set,the C-index of the RF mod-el was 0.892,and the Brier score was 0.112.The calibration curve and DCA curve showed that the predicted values of the RF model were close to the actual incidence rate,and it had a significant net benefit when the risk threshold range was 15%to 100%.Conclusion Among the four machine learning models constructed based on circumferential extent of the lesion,miR-204,miR-134,positive resection margin,depth of lesion invasion,and lesion length,the RF model has the best comprehen-sive predictive performance for the recurrence risk after ESD in early-stage esophageal cancer,with high discrimination,accuracy,and good clinical applicability.
姚成云;朱芳来;伍平
安庆市第一人民医院消化内科,安徽安庆,246000安庆市第一人民医院消化内科,安徽安庆,246000安庆市第一人民医院消化内科,安徽安庆,246000
医药卫生
早期食管癌内镜黏膜下剥离术术后复发微小核糖核酸-204微小核糖核酸-134机器学习模型随机森林模型最小绝对收缩与选择算子回归模型
early-stage esophageal cancerendoscopic submucosal dissectionpostoperative re-currencemicroRNA-204microRNA-134machine learning modelrandom forest modelleast ab-solute shrinkage and selection operator regression model
《实用临床医药杂志》 2026 (5)
81-87,7
2023年安徽省重点研究与开发计划项目(2023e07020089)安庆市2023年度医疗卫生类自筹经费科技计划项目(2023Z2010)
评论